Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PMX-60056 for Heparin Reversal in PCI
NCT01312935Phase 2Terminated
- Sponsor
- PolyMedix, Inc.
- Start
- Apr 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of delparantag, sponsored by PolyMedix, Inc.. Started Apr 2011; status: terminated.
02
Drugs
delparantag
Beyond the preview
Go deeper on NCT01312935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312935.